An immunohistochemical study of macrophage influx and the co- localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide

Histochemical Journal

Volumn 31, Issue 5, 1999, Pages 303-314

  Reddy, S ^a   Yip, S ^a   Karanam, M ^a   Poole, C A ^a   Ross, J M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL DESTRUCTION; CELL TRANSPORT; CONTROLLED STUDY; DIABETOGENESIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LOCALIZATION; FEMALE; HELPER CELL; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTRACELLULAR TRANSPORT; MALE; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; INCIDENCE; ISLETS OF LANGERHANS; MACROPHAGES; MICE; MICE, INBRED NOD; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; TIME FACTORS;

ANIMALIA;

EID: 0032781045     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1003765918017     Document Type: Article

References (61)

1. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA (1998) IL-1 produced and released endogenously with human islets inhibits β cell function. J. Clin Invest 102: 516-526.
2. Augustein P, Elefanty AG, Allison J, Harrison LC (1998) Apoptosis and beta cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41: 131-138.
3. Bacelj A, Charlton B, Mandel TE (1989) Prevention of cyclophosphamide-induced diabetes by anti-Vβ8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 38: 1492-1495.
4. Cailleau C, Diu-Hercend A, Ruuth E, Westwood R, Carnaud C (1997) Treatment with neutralizing antibodies specific for IL-1β prevents cyclophosphamide-induced diabetes in nonobese diabetic mice. Diabetes 46: 937-940.
5. Charlton B, Bacelj A, Mandel TE (1988) Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930-935.
6. Charlton B, Bacelj A, Slattery RM, Mandel TE (1989) Cyclophosphamide-induced diabetes in NOD/Wehi mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38: 441-447.
7. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, McDaniel ML (1992) Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β cell as a source and site of action of nitric oxide. J Clin Invest 90: 2384-2391.
8. Corbett JA, McDaniel ML (1995) Intra-islet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 181: 559-568.
9. Eisenbarth GS, Connelly J, Soeldner JS (1987) The natural history of type 1 diabetes. Diabetes Metab Rev 3: 873-891.
10. Eizirik DL, Pavlovic D (1997) Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM? Diabetes Metab Rev 13: 293-307.
11. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994a) Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 91: 9253-9256.
12. Eizirik DL, Sandler S, Welsh N, Cetkovic-cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom C (1994b) Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93: 1968-1974.
13. Foulis AK, Farquharson MA, Hardman R (1987) Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin-containing islets in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 333-343.
14. Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y (1982) Lymphocytic insulitis in a 'non-obese diabetic (NOD)' strain of mice: an immunohistochemical and electron microscope investigation. Biomed Res 3: 429-443.
15. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619-633.
16. Harada M (1987) Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice. Exp Clin Endocrinol 89: 251-258.
17. Harada M, Makino S (1984) Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27: 604-606.
18. Horio F, Fukuda M, Hattori M (1990) Peritoneal macrophage can transfer diabetes in NOD mice. Diabetes 39: (Suppl 1), 394.
19. Jansen A, Cook T, Taylor GM, Largen P, Riveros-Moreno V, Moncada S, Cattell V (1994a) Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 45: 1215-1219.
20. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA (1994b) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β-cell destruction in NOD mice. Diabetes 43: 667-675.
21. Kallman B, Burkart V, Kroncke K-D, Kolb-Bachoven V, Kolb H (1992) Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51: 671-678.
22. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoko T-A, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N (1995) Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738.
23. Kasuga A, Maruyama T, Takei I, Shimada A, Kasatani T, Watanabe K, Saruta T, Nakaki T, Habu S, Miyazaki J (1993) The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines. Diabetologia 36: 1252-1257.
24. Kasuga A, Nakaki T, Takei I, Takayama S, Ozawa Y, Maruyama T, Miyazaki J, Saruta T (1995) Nitric oxide is important for mouse beta-cell line killing by peritoneal exudate cells obtained from cyclophosphamide treated non-obese diabetic mice. Endocrine J 42: 259-263.
25. Kay TWH, Campbell IL, Oxbrow L, Harrison LC (1991a) Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-γ antibody. Diabetologia 34: 779-785.
26. Kay TWH, Campbell IL, Harrison LC (1991b) Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J Autoimmun 4: 263-276.
27. Kikutani H, Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51: 285-322.
28. Kleemann R, Rothe H, Kolb-Bachofen V, Xie Q-W, Nathan C, Martin S, Kolb H (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 328: 9-12.
29. Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low dose streptozotocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37: 21-27.
30. Kroncke K, Steiner L, Fehsel K, Kolb-Bachoven V (1995) Cytokine-activated capillary-forming islet endothelial cells lyse beta-cells via nitric oxide generation. Autoimmunity 21: 42.
31. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML (1995) Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: evidence for the involvement of nuclear factor κB in the signalling mechanism. Endocrinology 136: 4790-4795.
32. Lampeter EF, Signore A, Gale EAM, Pozzilli P (1989) Lessons from the NOD mouse for the pathogenesis and immunotherapy of human Type I (insulin-dependent) diabetes mellitus. Diabetologia 32: 703-708.
33. Lee KU, Amano K, Yoon JW (1988) Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989-991.
34. Lee M-S, Kim, Y-H, Kim K-W (1998) Apoptosis of pancreatic β-cells and lymphocytes detected in accelerated diabetes of NOD mice. Third Immunology of Diabetes Society Conference, Oak Brook, IL, USA, Abstract 40.
35. Mandrup-Poulsen T, Helqvist S, Molvig J, Wogensen LD, Nerup J (1989) Cytokines as immune effector molecules in autoimune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 4: 191-218.
36. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F, Johannesen J, Nemp J (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. In: Baekkeskov S, Hansen B eds. Human Diabetes - Genetic, Environmental and Auto-immune Etiology. Heidelberg: Springer-Verlag, pp. 169-193.
37. Qin HY, Singh B (1997) BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmun 10: 271-278.
38. Rabinovitch A (1993) Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1: 215-240.
39. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL (1990) Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71: 152-156.
40. Rabinovitch A, Suarez-Pinzon WL, Srydnadka K, Lakey JRT, Warnock GL, Rajotte RV (1994) Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79: 1058-1062.
41. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC (1996) Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology 137: 2093-2099.
42. Reddy S, Bibby NJ, Elliott RB (1988) Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia 31: 322-328.
43. Reddy S, Bibby NJ, Elliott RB (1991) Time course of immune markers in the NOD mouse: comparison between sexes and animals on an antidiabetogenic diet. Diabetes Nutrition Metab Clin Exp 4: 259-265.
44. Reddy S, Liu W, Elliott RB (1993) Distribution of pancreatic macrophages preceding and during insulitis in young NOD mice. Pancreas 8: 602-608.
45. Reddy S, Wu D, Swinney C, Elliott RB (1995) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 11: 16-25.
46. Reddy S, Kaill S, Poole CA, Ross J (1997) Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration. Histochem J 29: 53-64.
47. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H (1994) Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37: 1154-1158.
48. 2. Diabetologia 40: 641-646.
49. Sai P, Rivereau AS, Granier C, Haertle T, Martignat L (1996) Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin Exp Immunol 105: 330-337.
50. Sandler S, Andersson A, Hellerstrom C (1987) Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121: 1424-1431.
51. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N (1991) Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10: 241-253.
52. Shimada A, Takei I, Maruyama T et al. (1992) Transfer of peritoneal macrophages in NOD mice. Diabetes 41 (Suppl 1), 506, Abstract.
53. Signore A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL (1989) The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32: 282-289.
54. Southern C, Schulster D, Green IC (1990) Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α by an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276: 42-44.
55. Sumoski W, Baquerizo H, Rabinovitch A (1989) Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32: 792-796.
56. d monoclonal antibody. Diabetes 40: 1203-1209.
57. Welsh N, Eizirik DL, Bendtzen K, Sandler S (1991) Interleukin-1β induced nitric oxide production in isolated rat pancreatic islet requires gene transcription and may lead to inhibition of the Krebs cycle enzyme, aconitase. Endocrinology 129: 3167-3173.
58. Whittle BJR (1995) Nitric oxide in physiology and pathology. Histochem J 27: 727-737.
59. Xie Q-W, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
60. Yasunami R, Bach J-F (1988) Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18: 481-484.
61. Zhang ZL, Georgious HM, Mandel TE (1993) The effect of cyclophosphamide treatment on lymphocyte subsets in the non-obese diabetic mouse: a comparison of various lymphoid organs. Autoimmunity 15: 1-10.